Boult Wade Tennant
People » Dr Edward Ronan

Dr Edward Ronan

Partner

London

Contact
Download V-card
Address
Memberships
  • CIPA
  • EPI
Qualifications
  • Registered UPC Representative
  • European Patent Attorney
  • Chartered Patent Attorney
  • Certificate in Intellectual Property Law, Queen Mary University of London
  • DPhil Clinical Immunology, University of Oxford
  • MA Biological Sciences, University of Oxford

I am a Partner experienced in managing global patent portfolios as well as advising clients in relation to IP due diligence projects, for instance on their freedom to operate (FTO) in the market, the strength of their own portfolio and on the steps to take to improve their position.

My research background is in vaccinology, particularly viral vectors, and I have been fortunate that I have been able to continue working in this field as a Patent Attorney. I also find it refreshing that I am not confined to the technologies in which I have laboratory experience. As a Patent Attorney, I have been working a lot in the field of immuno-oncology. Understanding new techniques, both in this field and others, plus how they relate to the foundational and platform technologies, enables me to see where work can be done and therefore to advise the client on how to strengthen their position.

I like solving problems for clients: thinking creatively around their challenge and how to resolve it to their advantage is probably the aspect I enjoy the most. Being able to create a successful solution for a client is very fulfilling.

I thoroughly appreciated the support and training I received in helping me develop the skills that I was hired for when I joined Boult. As well as now being an external examiner for final diploma exams, I am actively involved in day-to-day training internally. Discussing a task with trainees, helping them understand the principles involved and what might need to be adjusted, then working together to produce that final product with the right advice for the client is highly rewarding.

This collaborative aspect applies throughout the firm, with colleagues in different practice groups always willing to advise. We have a positive ethos here at Boult.

Recent experience

Providing a dedicated women’s health company with strategic advice alongside management of its portfolios of purchased, newly originated and in licensed patent rights.

Successfully managing an antibody patent portfolio for a medium-sized biotech leading to acquisition of the program by a major pharmaceutical firm.

Ongoing EPO opposition work for a global pharmaceutical company.

Testimonials and recognitions
  • Recommended individual, IAM Patent 1000, 2024, 2023
  • Named as a key attorney, Legal 500, 2023
  • Listed as a World Leading Patent Professional, IAM Patent 1000, 2022
  • “Ed Ronan is a creative thinker.” Legal 500, 2022
Publications
Relevant Search Terms
Recommended Sites
Suggested Media
Recognitions
Additional Info
Languages
“I like solving problems for clients: thinking creatively around their challenge and how to resolve it to their advantage is probably the aspect I enjoy the most.”
Sector Experience
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Electronics and electrical devices
  • Medical devices
Medical devices and diagnostics 
  • Devices
  • Drug delivery
  • In vitro diagnostics
Pharmaceuticals
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)

I am a Partner experienced in managing global patent portfolios as well as advising clients in relation to IP due diligence projects, for instance on their freedom to operate (FTO) in the market, the strength of their own portfolio and on the steps to take to improve their position.

My research background is in vaccinology, particularly viral vectors, and I have been fortunate that I have been able to continue working in this field as a Patent Attorney. I also find it refreshing that I am not confined to the technologies in which I have laboratory experience. As a Patent Attorney, I have been working a lot in the field of immuno-oncology. Understanding new techniques, both in this field and others, plus how they relate to the foundational and platform technologies, enables me to see where work can be done and therefore to advise the client on how to strengthen their position.

I like solving problems for clients: thinking creatively around their challenge and how to resolve it to their advantage is probably the aspect I enjoy the most. Being able to create a successful solution for a client is very fulfilling.

I thoroughly appreciated the support and training I received in helping me develop the skills that I was hired for when I joined Boult. As well as now being an external examiner for final diploma exams, I am actively involved in day-to-day training internally. Discussing a task with trainees, helping them understand the principles involved and what might need to be adjusted, then working together to produce that final product with the right advice for the client is highly rewarding.

This collaborative aspect applies throughout the firm, with colleagues in different practice groups always willing to advise. We have a positive ethos here at Boult.

Recent experience

Providing a dedicated women’s health company with strategic advice alongside management of its portfolios of purchased, newly originated and in licensed patent rights.

Successfully managing an antibody patent portfolio for a medium-sized biotech leading to acquisition of the program by a major pharmaceutical firm.

Ongoing EPO opposition work for a global pharmaceutical company.

Testimonials and recognitions
  • Recommended individual, IAM Patent 1000, 2024, 2023
  • Named as a key attorney, Legal 500, 2023
  • Listed as a World Leading Patent Professional, IAM Patent 1000, 2022
  • “Ed Ronan is a creative thinker.” Legal 500, 2022
Publications
Relevant Search Terms
Recommended Sites
Suggested Media
Recognitions
Additional Info

Insights

image
Bulletin

EPO Guidelines for Examination: Patentability of antibodies

More
image
Bulletin

Updates to the EPO Guidelines for Examination: Patentability of plants and animals, human-derived cells, and methods of treatment by therapy

More
INSIGHTS